Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-007752·Bain Capital Life Sciences Fund II, L.P.
Schedule 13D ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 59045L205
Event date: 2026-01-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187
Shares: 0 · Class: 0%
- BCIP Life Sciences Associates, LPReported CIK 0001702921
Shares: 0 · Class: 0%
- BCLS II Investco, LPReported CIK 0001818893
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-007752
- Form type
- SCHEDULE 13D/A
- Filer
- Bain Capital Life Sciences Fund II, L.P.
- CIK
- CIK 1773187
- Filed
- Jan 08, 2026
- Reporting period
- Jan 06, 2026
- Description
- Schedule 13D beneficial ownership